相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression
Christian R. C. Kouakou et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2022)
Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
Christopher J. L. Stone et al.
CURRENT ONCOLOGY (2021)
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)
Shankar Siva et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
Rohann J. M. Correa et al.
RADIATION ONCOLOGY (2018)
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
Shankar Siva et al.
BMC CANCER (2018)
Patient-Reported Quality of Life Following Stereotactic Body Radiation Therapy for Primary Kidney Cancer: Results from a Prospective Cohort Study
A. Swaminath et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
Bin Wu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Pooled Analysis of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)
Shankar Siva et al.
CANCER (2018)
Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study
Erqi L. Pollom et al.
RADIOLOGY (2017)
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
Shankar Siva et al.
BJU INTERNATIONAL (2017)
Quantifying Health Utilities in Patients Undergoing Stereotactic Body Radiation Treatment for Liver Metastases for Use in Future Economic Evaluations
B. Warren et al.
CLINICAL ONCOLOGY (2017)
Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada
J. Amdahl et al.
CURRENT ONCOLOGY (2016)
Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases
Hayeon Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Evaluation of Health Economics in Radiation Oncology: A Systematic Review
Timothy K. Nguyen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship
Shankar Siva et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases
K. J. Roberts et al.
BRITISH JOURNAL OF SURGERY (2015)
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma
Lee Ponsky et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours
Yunbo Ma et al.
BJU INTERNATIONAL (2014)
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours
Tze M. Wah et al.
BJU INTERNATIONAL (2014)
Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non-Small-Cell Lung Cancer
Gunita Mitera et al.
JOURNAL OF ONCOLOGY PRACTICE (2014)
Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis
Sasha N. Bhan et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Long-Term Oncologic Outcomes After Radiofrequency Ablation for T1 Renal Cell Carcinoma
Sarah P. Psutka et al.
EUROPEAN UROLOGY (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Don Husereau et al.
VALUE IN HEALTH (2013)
A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma
Shankar Siva et al.
BJU INTERNATIONAL (2012)
Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up
Ephrem O. Olweny et al.
EUROPEAN UROLOGY (2012)
Long-term global quality of life in patients treated for colorectal liver metastases
B. Wiering et al.
BRITISH JOURNAL OF SURGERY (2011)
Management and Outcomes of Tumor Recurrence After Focal Ablation Renal Therapy
Alberto Breda et al.
JOURNAL OF ENDOUROLOGY (2010)
Differences in Patterns of Care: Reablation and Nephrectomy Rates After Needle Ablative Therapy for Renal Masses Stratified by Medical Specialty
Layron Long et al.
JOURNAL OF ENDOUROLOGY (2009)
Cryoablation or Radiofrequency Ablation of the Small Renal Mass A Meta-analysis
David A. Kunkle et al.
CANCER (2008)
Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors
Alejandra Mendez Romero et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: Cost-effectiveness analysis
Pari V. Pandharipande et al.
RADIOLOGY (2008)
Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study
Surena F. Matin et al.
JOURNAL OF UROLOGY (2006)
分享论文
